| Literature DB >> 8765019 |
T Brocker1, M Riedinger, K Karjalainen.
Abstract
We show that a chimeric T cell receptor (TCR) beta chain consisting of a single-chain Fv portion derived from a monoclonal antibody and the full TCR beta chain is able to assemble functionally with endogenous TCR/CD3 components and transfer the antibody specificity as well as the TCR specificity into TCR beta- as well as into TCR beta+ T cells. This allows the incorporation new non-major histocompatibility complex-restricted ligand specificities into the intact TCR/CD3 complex which can exploit the full range of biological activities of the endogenous TCR signaling machinery. This approach can provide wider opportunities to redirect T cells to virus or tumor antigen-bearing cells.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8765019 DOI: 10.1002/eji.1830260816
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532